rs4646092
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001229.5(CASP9):c.1048+95G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.23 in 1,158,462 control chromosomes in the GnomAD database, including 32,723 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 6678 hom., cov: 29)
Exomes 𝑓: 0.22 ( 26045 hom. )
Consequence
CASP9
NM_001229.5 intron
NM_001229.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.296
Publications
15 publications found
Genes affected
CASP9 (HGNC:1511): (caspase 9) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.422 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CASP9 | NM_001229.5 | c.1048+95G>A | intron_variant | Intron 7 of 8 | ENST00000333868.10 | NP_001220.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CASP9 | ENST00000333868.10 | c.1048+95G>A | intron_variant | Intron 7 of 8 | 1 | NM_001229.5 | ENSP00000330237.5 |
Frequencies
GnomAD3 genomes AF: 0.277 AC: 41952AN: 151600Hom.: 6649 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
41952
AN:
151600
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.222 AC: 223984AN: 1006744Hom.: 26045 AF XY: 0.222 AC XY: 113302AN XY: 510288 show subpopulations
GnomAD4 exome
AF:
AC:
223984
AN:
1006744
Hom.:
AF XY:
AC XY:
113302
AN XY:
510288
show subpopulations
African (AFR)
AF:
AC:
9320
AN:
22236
American (AMR)
AF:
AC:
3719
AN:
25790
Ashkenazi Jewish (ASJ)
AF:
AC:
5620
AN:
21520
East Asian (EAS)
AF:
AC:
2628
AN:
33352
South Asian (SAS)
AF:
AC:
13302
AN:
65120
European-Finnish (FIN)
AF:
AC:
13458
AN:
48796
Middle Eastern (MID)
AF:
AC:
1099
AN:
4204
European-Non Finnish (NFE)
AF:
AC:
164501
AN:
740634
Other (OTH)
AF:
AC:
10337
AN:
45092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
8347
16693
25040
33386
41733
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4774
9548
14322
19096
23870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.277 AC: 42019AN: 151718Hom.: 6678 Cov.: 29 AF XY: 0.274 AC XY: 20327AN XY: 74124 show subpopulations
GnomAD4 genome
AF:
AC:
42019
AN:
151718
Hom.:
Cov.:
29
AF XY:
AC XY:
20327
AN XY:
74124
show subpopulations
African (AFR)
AF:
AC:
17634
AN:
41302
American (AMR)
AF:
AC:
2923
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
AC:
882
AN:
3470
East Asian (EAS)
AF:
AC:
331
AN:
5164
South Asian (SAS)
AF:
AC:
867
AN:
4816
European-Finnish (FIN)
AF:
AC:
2961
AN:
10520
Middle Eastern (MID)
AF:
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15623
AN:
67914
Other (OTH)
AF:
AC:
560
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1457
2914
4372
5829
7286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
563
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.